Grant Award Summary

The National Cancer Institute (NCI) awarded a Cooperative Agreement totaling $975,000 to Rutgers The State University of New Jersey on March 21, 2026, under the Cancer Treatment Research program (CFDA 93.395) with a completion date of February 29, 2032. This award supports clinical trial infrastructure and administrative services for the Rutgers Cancer Institute and RWJBarnabas Health System. The initiative facilitates expanded cancer clinical research across multiple hospital sites within the RWJBarnabas Health system through an integrated academic health system model established via a Master Affiliation Agreement effective January 1, 2019.

Under this award, the Office of Human Research Services provides centralized research administration and oversight for all pediatric and adult oncology clinical trials across the health system. Key services include managing business, clinical, and regulatory functions across all phases of clinical research; coordinating clinical operations, quality assurance, and regulatory affairs; and supporting screening, enrollment, and National Cancer Institute-supported network clinical trials. The organizational structure comprises 158 full-time equivalents distributed across ten specialized offices, operating under a unified model with single Clinical Trial Management System, Institutional Review Board, and Electronic Medical Record to streamline research coordination and maximize patient enrollment across the expanded catchment area.